Decitabine

地西他滨,地西他宾,5-氮杂-2-脱氧胞苷

Decitabine是一种有效的DNA甲基化抑制剂,作用于HL-60和KG1a细胞时,IC50分别为100 ng/mL和1 ng/mL。

目录号
EY1780
EY1780
EY1780
EY1780
纯度
98.67%
98.67%
98.67%
98.67%
规格
5 mg
10 mg
50 mg
100 mg
原价
300
550
2000
3950
售价
300
550
2000
3950
库存
现货
现货
现货
现货
订购
订购
订购
订购
订购
订购
  • 生物活性

    Decitabine is a kind of deoxycytidine analog and an inducer of cellular differentiation. It is able to incorporate into DNA and form irreversible covalent bonds with DNA-methyltransferases at cytosine sites targeted for DNA methylation by increasing γ-globin expression through a posttranscriptional mechanism independent of DNA methylation. Decitabine has been shown substantial efficacy in reactivating epigenetically silenced tumor suppressor genes in vitro. In colon cancer cell lines, decitabine can increase the histone H3-lysine 9 acetylation: methylation ratio at the unmethylated hMLH1 and MGMT promoters in HCT116 and RKO cells, respectively. In T24 bladder cancer cells, decitabine can increase histone H3-lysine 9 acetylation and histone H3-lysine 4 methylation at the unmethylated p14 promoter.

  • 体外研究

  • 体内研究

    30% Propylene glycol, 5% Tween 80, 65% D5W(5%葡萄糖水溶液)

  • 激酶实验

  • 细胞实验

    0 -100 ng/mL

  • 动物实验

    ≤2.5 mg/kg 腹腔注射

  • 不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 AKm系数


    例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。


  • 参考文献

    [1] Shaker S, et al. Leuk Res, 2003, 27(5), 437-444.
    [2] Zhu, W G., et al., 2001. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer research. 61(4): 1327-33.
    [3] Takebayashi, S., et al., 2001. 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation. Biochemical and biophysical research communications. 288(4): 921-6.
    [4] Jones, P A., et al., 1980. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 20(1): 85-93.

    分子式
    C8H12N4O4
    分子量
    228.21
    CAS号
    2353-33-5
    储存方式
    ﹣20 ℃冷藏长期储存。冰袋运输
    溶剂(常温)
    DMSO
    50 mg/mL
    Water
    10 mg/mL
    Ethanol
    <1 mg/mL

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    NCT Number Conditions Interventions Sponsor/Collaborators Phases Start Date Last Updated
    NCT03045510 Myelodysplastic Syndromes Drug: decitabine Shandong University Phase 2 2016-12-01 2017-02-06
    NCT01277484 Myelodysplastic Syndrome|Acute Myeloid Leukemia Drug: Decitabine Seoul St. Mary's Hospital|Janssen, LP Phase 1 2011-01-01 2015-11-18
    NCT02316028 Liver Metastasis|Colorectal Cancer Drug: Decitabine Universitair Ziekenhuis Brussel|Janssen, LP Phase 1|Phase 2 2014-03-01 2016-09-14
    NCT01251627 Chronic Myelomonocytic Leukemia Drug: Decitabine Fondazione Italiana Sindromi Mielodisplastiche Onlus|Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte Phase 2 2010-04-01 2017-02-14
    NCT01633099 Untreated Adult Acute Myeloid Leukemia|Effect of Drugs|Drug Safety Drug: Decitabine Jianxiang Wang|Xian-Janssen Pharmaceutical Ltd.|Chinese Academy of Medical Sciences Phase 3 2012-05-01 2012-07-04
    NCT01568333 Immune Thrombocytopenia Drug: Decitabine Shandong University|Qingdao University|Shandong Provincial Hospital Phase 2 2015-06-01 2016-07-26
    NCT00744757 Myelodysplastic Syndrome Drug: Decitabine Johnson & Johnson Taiwan Ltd Phase 2 2008-08-01 2013-08-26
    NCT02252107 Acute Myeloid Leukemia (AML) Drug: decitabine Radboud University Phase 2 2014-10-01 2016-04-06
    NCT02257138 Leukemia|Myeloproliferative Diseases Drug: Ruxolitinib|Drug: Decitabine M.D. Anderson Cancer Center|Incyte Corporation Phase 1|Phase 2 2015-02-01 2017-03-23
    NCT00349596 Acute Lymphocytic Leukemia Drug: Decitabine M.D. Anderson Cancer Center|Eisai Inc. Phase 1 2006-07-01 2014-10-13
    NCT03080766 Acute Myeloid Leukemia|Complex Karyotype Drug: Decitabine The University of Hong Kong|Janssen, LP Phase 2 2017-03-01 2017-03-09
    NCT02141477 Leukemia Drug: Omacetaxine|Drug: Decitabine M.D. Anderson Cancer Center|Teva Pharmaceuticals USA Phase 2 2015-05-01 2016-12-06
    NCT00477386 Ovarian Cancer Drug: decitabine Indiana University|Eisai Inc. Phase 1|Phase 2 2007-07-01 2014-09-19
    NCT00414310 Myelodysplastic Syndrome|Acute Myelogenous Leukemia Drug: Decitabine|Drug: Valproic Acid M.D. Anderson Cancer Center|Eisai Inc. Phase 2 2006-12-01 2015-07-15
    NCT00866073 Acute Myeloid Leukemia Drug: Decitabine 15 mg/m2 i.v. University Hospital Freiburg Phase 2 2003-04-01 2009-03-19
    NCT02264873 Leukemia, Lymphoblastic, Acute|Leukemia, Myeloid Acute|Hematopoetic Myelodysplasia Drug: Decitabine University of Florida Phase 1 2014-10-01 2016-11-29
    NCT01893320 Leukemia Drug: Vosaroxin|Drug: Decitabine M.D. Anderson Cancer Center|Sunesis Pharmaceuticals Phase 1|Phase 2 2013-07-18 2017-02-03
    NCT02499861 Cancer Drug: Decitabine and Genistein St. Justine's Hospital Phase 1|Phase 2 2015-07-01 2016-05-08
    NCT01687400 Leukemia, Myeloid, Acute|Myelodysplastic Syndromes Drug: decitabine Washington University School of Medicine Phase 2 2013-02-12 2017-01-26
    NCT01786343 Leukemia Drug: Decitabine M.D. Anderson Cancer Center Phase 2 2013-02-01 2016-08-25

    注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 :
  • 收件地址 :
  • 电话号码 :
  • 单位名称 :
  • 产品货号 :
  • 产品规格 :
  • 发票抬头以及单位税号 :